Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-24 @ 7:42 PM
NCT ID:
NCT00048503
Eligibility Criteria:
Inclusion Criteria:
* Newly-diagnosed AML
* Leukemia in remission
* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
Exclusion Criteria:
* Acute Promyelocytic Leukemia (APL)
* Previous History of myelodysplasia or antecedent hematologic malignancy
* Previous therapy with a farnesyl transferase inhibitor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT00048503
Study Brief:
Protocol Section:
NCT00048503